These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Normocalcemic primary hyperparathyroidism: a growing problem]. Martínez Díaz-Guerra G; Guadalix Iglesias S; Hawkins Carranza F Med Clin (Barc); 2013 Aug; 141(3):125-9. PubMed ID: 23199831 [TBL] [Abstract][Full Text] [Related]
6. [News in endocrinology: Management of asymptomatic primary hyperparathyroidism in 2014]. Köhler BB; Philippe J Rev Med Suisse; 2015 Jan; 11(456-457):58-61. PubMed ID: 25799652 [TBL] [Abstract][Full Text] [Related]
7. Bone densitometry: patients with asymptomatic primary hyperparathyroidism part I. Technical report. Erlichman M; Holohan TV Health Technol Assess (Rockv); 1995 Dec; (6):1-30. PubMed ID: 8938232 [TBL] [Abstract][Full Text] [Related]
8. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism. Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327 [TBL] [Abstract][Full Text] [Related]
11. [CIP and CAP fragments of parathormone and selected parameters of calcium-phosphate balance in patients with chronic kidney disease treated with repeated haemodialysis]. Polak-Jonkisz D; Zwolińska D; Nahaczewska W Pediatr Endocrinol Diabetes Metab; 2010; 16(1):25-8. PubMed ID: 20529602 [TBL] [Abstract][Full Text] [Related]
12. Normocalcaemic primary hyperparathyroidism: An update on diagnostic and management challenges. Dawood NB; Yan KL; Shieh A; Livhits MJ; Yeh MW; Leung AM Clin Endocrinol (Oxf); 2020 Nov; 93(5):519-527. PubMed ID: 32803770 [TBL] [Abstract][Full Text] [Related]
13. Normocalcemic primary hyperparathyroidism-characteristics and clinical significance of an emerging entity. Shlapack MA; Rizvi AA; Lopez FA Am J Med Sci; 2012 Feb; 343(2):163-166. PubMed ID: 22173046 [TBL] [Abstract][Full Text] [Related]
15. Evaluation and Management of Elevated Parathyroid Hormone Levels in Normocalcemic Patients. Cusano NE Med Clin North Am; 2021 Nov; 105(6):1135-1150. PubMed ID: 34688419 [TBL] [Abstract][Full Text] [Related]
17. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1. Milanesi A; Yu R; Geller SA; Burton D; Deftos LJ; Wolin EM Pancreas; 2011 May; 40(4):634-7. PubMed ID: 21483254 [TBL] [Abstract][Full Text] [Related]
18. Derivation of a cost-saving screening strategy for asymptomatic primary hyperparathyroidism. Nguyen-Lee JJ; Paciuc M; Guerra R; Esnaola N; Zanocco KA; Zheng F Surgery; 2020 Jan; 167(1):155-159. PubMed ID: 31604587 [TBL] [Abstract][Full Text] [Related]
19. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. Shah VN; Bhadada SK; Bhansali A; Behera A; Mittal BR; Bhavin V J Postgrad Med; 2012; 58(2):107-11. PubMed ID: 22718053 [TBL] [Abstract][Full Text] [Related]
20. Primary hyperparathyroidism. Oberger Marques JV; Moreira CA Best Pract Res Clin Rheumatol; 2020 Jun; 34(3):101514. PubMed ID: 32336576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]